Accepted for/Published in: JMIR Research Protocols
Date Submitted: Jun 23, 2026
Date Accepted: Nov 2, 2026
Protocol for the FAPI-DGC study: a prospective exploratory single-centre diagnostic imaging study evaluating the diagnostic performance of ¹⁸F-FAPI PET in diffuse gastric cancer
ABSTRACT
Background:
Accurate preoperative staging of gastric cancer remains challenging, particularly in diffuse gastric cancer (DGC), which is characterised by poorly differentiated and signet ring cell histology, diffuse submucosal infiltration, and a high propensity for peritoneal dissemination. Conventional imaging modalities, including contrast-enhanced computed tomography (CT) and positron emission tomography (PET) using fluorodeoxyglucose, have limited diagnostic performance in this subtype. Fibroblast activation protein inhibitor (FAPI) PET targets cancer-associated fibroblasts, which are abundant in DGC, and may enable improved visualisation of tumour extent beyond tumour cell metabolism.
Objective:
This study aims to explore the feasibility, clinical utility and safety of ¹⁸F-FAPI PET for preoperative staging of DGC (the FAPI-DGC study).
Methods:
This is a multicentre, prospective, exploratory imaging study enrolling 20 patients with histologically confirmed diffuse gastric cancer who are scheduled for curative resection or staging laparoscopy. All participants will undergo ¹⁸F-FAPI-74 PET/CT in addition to standard preoperative investigations. Preoperative T, N and M staging will be determined based on conventional imaging alone and on imaging incorporating FAPI-PET findings. These staging assessments will be compared with postoperative pathological staging as the reference standard. The primary outcome is the exploratory assessment of preoperative staging accuracy. Secondary outcomes include detection rates of primary and metastatic lesions, correlations between FAPI uptake and histopathological features such as fibrosis and fibroblast activation protein expression, associations with tumour markers, and safety outcomes. Statistical analyses will be descriptive and hypothesis-generating.
Results:
Participant enrolment is ongoing. This study is expected to generate feasibility data and preliminary estimates regarding the potential clinical utility of ¹⁸F-FAPI PET for preoperative staging of diffuse gastric cancer. The findings will inform the design of future multicentre confirmatory studies.
Conclusions:
This protocol describes a prospective exploratory imaging study evaluating ¹⁸F-FAPI PET in diffuse gastric cancer. Publication of the protocol will enhance transparency, establish an a priori record of the study methodology, and facilitate interpretation of future study findings. Clinical Trial: Japan Registry of Clinical Trials (jRCTs031250386).
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.